Ac Immune Stock Price Prediction

ACIU Stock  USD 2.37  0.01  0.42%   
At this time, the RSI of AC Immune's share price is approaching 39. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling AC Immune, making its price go up or down.

Oversold Vs Overbought

39

 
Oversold
 
Overbought
AC Immune stock price prediction is an act of determining the future value of AC Immune shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of AC Immune's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of AC Immune and does not consider all of the tangible or intangible factors available from AC Immune's fundamental data. We analyze noise-free headlines and recent hype associated with AC Immune, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting AC Immune's stock price prediction:
EPS Estimate Next Quarter
(0.20)
EPS Estimate Current Year
(0.73)
EPS Estimate Next Year
(0.23)
Wall Street Target Price
10.48
EPS Estimate Current Quarter
(0.13)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of AC Immune based on different types of headlines from major news networks to social media. The ACIU stock price prediction module provides an analysis of price elasticity to changes in media outlook on AC Immune over a specific investment horizon. Using AC Immune hype-based prediction, you can estimate the value of AC Immune from the perspective of AC Immune response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards AC Immune using AC Immune's stock options and short interest. It helps to benchmark the overall future attitude of investors towards ACIU using crowd psychology based on the activity and movement of AC Immune's stock price.

AC Immune Implied Volatility

    
  0.0  
AC Immune's implied volatility exposes the market's sentiment of AC Immune stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if AC Immune's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that AC Immune stock will not fluctuate a lot when AC Immune's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in AC Immune. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in AC Immune to buy its stock at a price that has no basis in reality. In that case, they are not buying ACIU because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

AC Immune after-hype prediction price

    
  USD 2.38  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out AC Immune Basic Forecasting Models to cross-verify your projections.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AC Immune's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.122.326.97
Details
Naive
Forecast
LowNextHigh
0.042.146.79
Details
3 Analysts
Consensus
LowTargetHigh
10.0811.0812.30
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.22-0.15-0.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AC Immune. Your research has to be compared to or analyzed against AC Immune's peers to derive any actionable benefits. When done correctly, AC Immune's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AC Immune.

AC Immune After-Hype Price Prediction Density Analysis

As far as predicting the price of AC Immune at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AC Immune or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of AC Immune, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

AC Immune Estimiated After-Hype Price Volatility

In the context of predicting AC Immune's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AC Immune's historical news coverage. AC Immune's after-hype downside and upside margins for the prediction period are 0.12 and 7.03, respectively. We have considered AC Immune's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.37
2.38
After-hype Price
7.03
Upside
AC Immune is very risky at this time. Analysis and calculation of next after-hype price of AC Immune is based on 3 months time horizon.

AC Immune Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as AC Immune is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AC Immune backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AC Immune, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.65 
4.64
  0.29 
  0.11 
8 Events / Month
13 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.37
2.38
0.00 
1,055  
Notes

AC Immune Hype Timeline

AC Immune is presently traded for 2.37. The entity has historical hype elasticity of -0.29, and average elasticity to hype of competition of -0.11. ACIU is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.65%. %. The volatility of related hype on AC Immune is about 2796.71%, with the expected price after the next announcement by competition of 2.26. About 42.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.55. Some equities with similar Price to Book (P/B) outperform the market in the long run. AC Immune recorded a loss per share of 0.7. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out AC Immune Basic Forecasting Models to cross-verify your projections.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

AC Immune Related Hype Analysis

Having access to credible news sources related to AC Immune's direct competition is more important than ever and may enhance your ability to predict AC Immune's future price movements. Getting to know how AC Immune's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AC Immune may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
PMVPPmv PharmaceuticalsInc(0.01)4 per month 3.64  0.04  7.45 (5.88) 21.67 
ELYMEliem Therapeutics(0.12)7 per month 3.04  0.07  4.17 (6.23) 79.43 
MNOVMediciNova(0.01)8 per month 0.00 (0.09) 4.55 (3.95) 14.01 
PHVSPharvaris BV(1.28)6 per month 0.00 (0.08) 6.33 (8.97) 24.54 
PEPGPepGen(0.60)8 per month 5.83  0.12  17.58 (10.87) 67.46 
RGNXRegenxbio 0.13 12 per month 3.75  0.05  11.65 (5.76) 27.26 
ANEBAnebulo Pharmaceuticals(0.05)5 per month 3.50  0.04  6.20 (5.51) 20.75 
IVVDInvivyd 0.48 6 per month 0.00 (0.12) 11.00 (8.91) 67.02 
ABEOAbeona Therapeutics(0.91)8 per month 0.00 (0.02) 8.32 (7.63) 36.43 
BDTXBlack Diamond Therapeutics(0.19)7 per month 4.35  0.16  15.50 (7.18) 26.97 
SYBXSynlogic(0.02)8 per month 0.00 (0.08) 6.15 (5.38) 60.85 
EFTREffector Therapeutics(1.57)7 per month 0.00 (0.09) 11.60 (15.14) 98.22 
GRTXGalera Therapeutics(0.02)6 per month 5.36  0.04  14.29 (11.11) 49.76 
ICVXIcosavax(0.07)9 per month 1.28  0.15  8.15 (4.36) 50.81 
FIXXHomology Medicines 0.07 5 per month 11.22  0.12  10.00 (3.26) 1,764 
STOKStoke Therapeutics(0.69)7 per month 4.64  0.15  22.86 (8.17) 64.17 
BCELAtreca Inc 0.00 0 per month 0.00 (0.02) 29.03 (22.73) 161.02 
FDMT4D Molecular TherapeuticsInc 1.48 11 per month 4.53  0.08  6.66 (6.76) 99.59 
AVTEAerovate Therapeutics 0.32 8 per month 4.93  0.05  11.11 (6.86) 28.53 
ACRVAcrivon Therapeutics Common(0.35)5 per month 4.91  0.15  17.65 (10.59) 73.69 
OPTOpthea(0.19)4 per month 3.03  0.07  8.00 (5.58) 19.28 
ANTXAN2 Therapeutics(0.05)8 per month 0.00 (0.21) 3.78 (9.57) 77.96 

AC Immune Additional Predictive Modules

Most predictive techniques to examine ACIU price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ACIU using various technical indicators. When you analyze ACIU charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About AC Immune Predictive Indicators

The successful prediction of AC Immune stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AC Immune, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AC Immune based on analysis of AC Immune hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AC Immune's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AC Immune's related companies.
 2023 2024 (projected)
Dividend Yield4.0E-53.5E-5
Price To Sales Ratio24.0634.98

Story Coverage note for AC Immune

The number of cover stories for AC Immune depends on current market conditions and AC Immune's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AC Immune is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AC Immune's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

AC Immune Short Properties

AC Immune's future price predictability will typically decrease when AC Immune's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AC Immune often depends not only on the future outlook of the potential AC Immune's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AC Immune's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding84.7 M
Cash And Short Term Investments103 M
When determining whether AC Immune is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ACIU Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ac Immune Stock. Highlighted below are key reports to facilitate an investment decision about Ac Immune Stock:
Check out AC Immune Basic Forecasting Models to cross-verify your projections.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for ACIU Stock analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is AC Immune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AC Immune. If investors know ACIU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AC Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.70)
Revenue Per Share
0.175
Quarterly Revenue Growth
14.8 K
Return On Assets
(0.18)
Return On Equity
(0.33)
The market value of AC Immune is measured differently than its book value, which is the value of ACIU that is recorded on the company's balance sheet. Investors also form their own opinion of AC Immune's value that differs from its market value or its book value, called intrinsic value, which is AC Immune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AC Immune's market value can be influenced by many factors that don't directly affect AC Immune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AC Immune's value and its price as these two are different measures arrived at by different means. Investors typically determine if AC Immune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AC Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.